Literature DB >> 19808509

Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction.

Ta-Chuan Hung1, Yoriyasu Suzuki, Takashi Urashima, Anthony Caffarelli, Grant Hoyt, Ahmad Y Sheikh, Alan C Yeung, Irving Weissman, Robert C Robbins, Jeff W M Bulte, Jeff M Bulte, Phillip C Yang.   

Abstract

BACKGROUND: We tested the hypothesis that multimodality imaging of mouse embryonic stem cells (mESCs) provides accurate assessment of cellular location, viability, and restorative potential after transplantation into different zones of myocardial infarction. METHODS AND
RESULTS: Mice underwent left anterior descending artery ligation followed by transplantation of dual-labeled mESCs with superparamagnetic iron oxide and luciferase via direct injection into 3 different zones of myocardial infarction: intra-infarction, peri-infarction, and normal (remote). One day after transplantation, magnetic resonance imaging enabled assessment of the precise anatomic locations of mESCs. Bioluminescence imaging allowed longitudinal analysis of cell viability through detection of luciferase activity. Subsequent evaluation of myocardial regeneration and functional restoration was performed by echocardiography and pressure-volume loop analysis. Using 16-segment analysis, we demonstrated precise localization of dual-labeled mESCs. A strong correlation between histology and magnetic resonance imaging was established (r=0.962, P=0.002). Bioluminescent imaging data demonstrated that cell viability in the remote group was significantly higher than in other groups. Echocardiography and pressure-volume loop analysis revealed improved functional restoration in animals treated with mESCs, although myocardial regeneration was not observed.
CONCLUSIONS: Multimodality evaluation of mESC engraftment in the heterogeneous tissue of myocardial infarction is possible. Magnetic resonance imaging demonstrated accurate anatomic localization of dual-labeled mESCs. Bioluminescent imaging enabled assessment of variable viability of mESCs transplanted into the infarcted myocardium. Echocardiography and pressure-volume loop analysis validated the restorative potential of mESCs. Although mESCs transplanted into the remote zone demonstrated the highest viability, precise delivery of mESCs into the peri-infarction region might be equally critical in restoring the injured myocardium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19808509     DOI: 10.1161/CIRCIMAGING.108.767343

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  20 in total

Review 1.  In vivo imaging of embryonic stem cell therapy.

Authors:  Han Jiang; Zhen Cheng; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-24       Impact factor: 9.236

2.  In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.

Authors:  Ahmad Y Sheikh; Bruno C Huber; Kazim H Narsinh; Joshua M Spin; Koen van der Bogt; Patricia E de Almeida; Katherine J Ransohoff; Daniel L Kraft; Giovanni Fajardo; Diego Ardigo; Julia Ransohoff; Daniel Bernstein; Michael P Fischbein; Robert C Robbins; Joseph C Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

3.  Molecular Imaging of Stem Cell Transplantation in Myocardial Disease.

Authors:  Jaehoon Chung; Phillip C Yang
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-02-03

4.  Utility of dual-modality bioluminescence and MRI in monitoring stem cell survival and impact on post myocardial infarct remodeling.

Authors:  Hualei Zhang; Hui Qiao; Ashley Bakken; Fabao Gao; Bin Huang; Yingqiu Y Liu; Wafik El-Deiry; Victor A Ferrari; Rong Zhou
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

5.  Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging.

Authors:  Rosalinda T Castaneda; Sophie Boddington; Tobias D Henning; Mike Wendland; Lydia Mandrussow; Siyuan Liu; Heike Daldrup-Link
Journal:  Pediatr Radiol       Date:  2011-05-19

6.  Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.

Authors:  Paul J Kim; Morteza Mahmoudi; Xiaohu Ge; Yuka Matsuura; Ildiko Toma; Scott Metzler; Nigel G Kooreman; John Ramunas; Colin Holbrook; Michael V McConnell; Helen Blau; Phillip Harnish; Eric Rulifson; Phillip C Yang
Journal:  Circ Res       Date:  2015-02-05       Impact factor: 17.367

Review 7.  Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.

Authors:  Arunima Panda; Narasimman Gurusamy; Sheeja Rajasingh; Hannah-Kaye Carter; Edwin L Thomas; Johnson Rajasingh
Journal:  Differentiation       Date:  2020-01-10       Impact factor: 3.880

8.  Noninvasive monitoring of oxidative stress in transplanted mesenchymal stromal cells.

Authors:  Peter J Psaltis; Karen M Peterson; Rende Xu; Federico Franchi; Tyra Witt; Ian Y Chen; Amir Lerman; Robert D Simari; Sanjiv S Gambhir; Martin Rodriguez-Porcel
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

9.  Graphite oxide nanoparticles with diameter greater than 20 nm are biocompatible with mouse embryonic stem cells and can be used in a tissue engineering system.

Authors:  I-Ning E Wang; Joshua T Robinson; Grace Do; Guosong Hong; Danny R Gould; Hongjie Dai; Phillip C Yang
Journal:  Small       Date:  2013-12-23       Impact factor: 13.281

10.  Myocardial viability of the peri-infarct region measured by T1 mapping post manganese-enhanced MRI correlates with LV dysfunction.

Authors:  Yuko Tada; Shahriar Heidary; Atsushi Tachibana; Junaid Zaman; Evgenios Neofytou; Rajesh Dash; Joseph C Wu; Phillip C Yang
Journal:  Int J Cardiol       Date:  2019-01-31       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.